Handelsbanken Fonder Ab Acadia Pharmaceuticals Inc Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 47,633 shares of ACAD stock, worth $704,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,633

Previous 40,833 16.65%

Holding current value

$704,492

Previous $664,000 10.39%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$15.14 - $19.14 $102,952 - $130,152	6,800 Added 16.65%	47,633 $733,000
Q1 2024 May 13, 2024	BUY	$17.79 - $30.86 $163,668 - $283,912	9,200 Added 29.08%	40,833 $755,000
Q4 2023 Feb 01, 2024	BUY	$20.78 - $31.77 $14,546 - $22,239	700 Added 2.26%	31,633 $990,000
Q2 2023 Aug 02, 2023	BUY	$17.8 - $25.65 $97,900 - $141,075	5,500 Added 21.63%	30,933 $741,000
Q4 2022 Feb 07, 2023	BUY	$14.2 - $18.63 $11,360 - $14,904	800 Added 3.25%	25,433 $405,000
Q2 2022 Aug 03, 2022	BUY	$13.01 - $27.22 $48,137 - $100,714	3,700 Added 17.68%	24,633 $347,000
Q1 2022 May 11, 2022	BUY	$20.94 - $27.5 $39,786 - $52,250	1,900 Added 9.98%	20,933 $507,000
Q4 2021 Feb 08, 2022	SELL	$16.79 - $27.09 $230,023 - $371,133	-13,700 Reduced 41.85%	19,033 $444,000
Q2 2021 Aug 03, 2021	BUY	$19.4 - $27.42 $182,360 - $257,748	9,400 Added 40.29%	32,733 $798,000
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $916,053 - $1.23 Million	23,333 New	23,333 $1.13 Million
Q2 2018 Jul 11, 2018	SELL	$15.07 - $22.34 $4.9 Million - $7.26 Million	-325,000 Closed	0 $0
Q1 2018 May 18, 2018	BUY	$22.47 - $32.33 $2.58 Million - $3.72 Million	115,000 Added 54.76%	325,000 $7.3 Million
Q4 2017 Feb 08, 2018	BUY	$26.84 - $39.14 $536,800 - $782,800	20,000 Added 10.53%	210,000 $6.32 Million
Q3 2017 Oct 24, 2017	BUY	$29.49 - $38.37 $5.6 Million - $7.29 Million	190,000	190,000 $7.16 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Acadia Pharmaceuticals Inc Transaction History